Opaleye Management Inc. Concert Pharmaceuticals, Inc. Transaction History

Opaleye Management Inc.

  • $390 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 18, 2021
SELL
$4.86 - $13.07 $1.23 Million - $3.32 Million
-254,000 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$9.48 - $12.84 $1.46 Million - $1.98 Million
154,000 Added 154.0%
254,000 $3.21 Million
Q3 2020

Nov 16, 2020
BUY
$8.67 - $10.82 $867,000 - $1.08 Million
100,000 New
100,000 $982,000

Others Institutions Holding CNCE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CONCERT PHARMACEUTICALS, INC.

CNCE Quotes by TradingView
  • Ticker CNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,934,600
  • Description
  • Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...
More about CNCE
Track This Portfolio

Track Opaleye Management Inc. Portfolio

Follow Opaleye Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email